NCT04874935View on ClinicalTrials.gov

The Possible Efficacy and Safety of Lansoprazole Co-administration With Neoadjuvant Chemotherapy in Women With Breast Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

June 10, 2021

Primary Completion Date

November 5, 2022

Study Completion Date

November 5, 2022

Conditions
Breast Cancer
Interventions
DRUG

Lansoprazole

administration of lansoprazole 60 mg twice daily 4 days before starting neoadjuvant chemotherapy regimen and continue till end of chemotherapy cycles

DRUG

Placebo

administration of Placebo capsule twice daily 4 days before starting neoadjuvant chemotherapy regimen and continue till end of chemotherapy cycles

Trial Locations (1)

32511

Faculty of Pharmacy, Tanta

All Listed Sponsors
lead

Tanta University

OTHER